Compositions for targeted imaging and therapy
US9408928B2 · kind B2 · utility
2Cited by
17References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 2008 |
| Grant date | Aug 9, 2016 |
| Priority date | — |
| Expiry date | Jan 12, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the field of radiochemistry, nuclear imaging, radionuclide therapy and chemical synthesis. More particularly, it concerns a strategy for radiolabeling target ligands. It further concerns methods of using those radiolabeled ligands for imaging, radionuclide therapy and tissue-specific disease imaging.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.